Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › OVID

SILVERARC CAPITAL MANAGEMENT, LLC position in OVID

OVID THERAPEUTICS INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 5,950,000 shares of OVID (OVID THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.8M, representing 1.89% of its reported portfolio and ranking #15 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)5.95M sh
Reported value held$14.82M
Portfolio Weight1.89%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's OVID position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in OVID in Q1 2026 at 1,000,000 shares (US$2.2M). The position peaked in Q3 2026 at 5,950,000 shares, worth US$14.8M. Across 3 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,950,000 shares valued at US$14.8M — an increase of 2,848,871 shares quarter over quarter.. Notable position changes include a 210% increase in Q2 2026 (shares fell 7% over the following quarter), a 92% increase in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.00M $2.22M New
Q2 2026 3.10M $8.34M Add
Q3 2026 5.95M $14.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OVID and 13F data

OVID (OVID THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$27.3M), ADAR1 Capital Management, LLC (US$20.0M), STEMPOINT CAPITAL LP (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OVID

All OVID fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held OVID?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in OVID?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 5.95M shares of OVID (OVID THERAPEUTICS INC), valued at $14.82M, representing 1.89% of its reported portfolio and ranking #15.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling OVID?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in OVID. The position peaked in Q3 2026 at 5.95M shares.

Which other funds hold OVID?

Other major institutional holders of OVID include Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, STEMPOINT CAPITAL LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.